logo
Analysts Offer Insights on Real Estate Companies: Mapletree Commercial (OtherMPCMF) and Extra Space Storage (EXR)

Analysts Offer Insights on Real Estate Companies: Mapletree Commercial (OtherMPCMF) and Extra Space Storage (EXR)

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Mapletree Commercial (MPCMF – Research Report) and Extra Space Storage (EXR – Research Report).
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mapletree Commercial (MPCMF)
In a report released today, Geraldine Wong from DBS maintained a Buy rating on Mapletree Commercial, with a price target of S$1.50. The company's shares closed last Monday at $0.85.
According to TipRanks.com, Wong is a 3-star analyst with an average return of 2.4% and a 60.5% success rate. Wong covers the NA sector, focusing on stocks such as CDL Hospitality Trusts, Mapletree Logistics, and Frasers Centrepoint.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mapletree Commercial with a $1.17 average price target.
Extra Space Storage (EXR)
In a report released today, Juan C. Sanabria from BMO Capital maintained a Hold rating on Extra Space Storage, with a price target of $165.00. The company's shares closed last Wednesday at $149.34.
According to TipRanks.com, Sanabria is a 2-star analyst with an average return of 0.2% and a 46.5% success rate. Sanabria covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., National Storage Affiliates, and National Health Investors.
Extra Space Storage has an analyst consensus of Moderate Buy, with a price target consensus of $153.92, implying a 1.2% upside from current levels. In a report issued on July 23, Wells Fargo also maintained a Hold rating on the stock with a $160.00 price target.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's Why Baron Real Estate Fund Sold Extra Space Storage (EXR) in Q2
Here's Why Baron Real Estate Fund Sold Extra Space Storage (EXR) in Q2

Yahoo

time21 hours ago

  • Yahoo

Here's Why Baron Real Estate Fund Sold Extra Space Storage (EXR) in Q2

Baron Funds, an investment management company, released its 'Baron Real Estate Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 3.61% (Institutional Shares) in the quarter compared to a 1.46% decline for the MSCI US REIT Index (the REIT Index) and a 6.13% gain for the MSCI USA IMI Extended Real Estate Index (the MSCI Real Estate Index). In addition, please check the fund's top five holdings to know its best picks in 2025. Shop Top Mortgage Rates A quicker path to financial freedom Your Path to Homeownership Personalized rates in minutes In its second-quarter 2025 investor letter, Baron Real Estate Fund highlighted stocks such as Extra Space Storage Inc. (NYSE:EXR). Extra Space Storage Inc. (NYSE:EXR) is a self-administered and self-managed REIT. The one-month return of Extra Space Storage Inc. (NYSE:EXR) was -8.88%, and its shares lost 15.55% of their value over the last 52 weeks. On August 1, 2025, Extra Space Storage Inc. (NYSE:EXR) stock closed at $139.30 per share, with a market capitalization of $30.87 billion. Baron Real Estate Fund stated the following regarding Extra Space Storage Inc. (NYSE:EXR) in its second quarter 2025 investor letter: "We also sold our position in Extra Space Storage Inc. (NYSE:EXR) during the quarter. While we are long-term bullish on the prospects for self storage real estate (excellent real estate businesses with less cyclical demand, pricing power, low capital intensity, scale advantages), we are concerned that lackluster existing home sales caused by the well-known 'lock in effect' may weigh on self-storage demand and market rents for longer than is widely believed. We view current share price valuations as fair, not overly cheap. As such, for now we opted to reallocate capital to other investments with superior return potential. We may revisit Extra Space Storage, a best-in-class company, in the future." An aerial view of a self-storage facility, its parking lot full with cars and RV's. Extra Space Storage Inc. (NYSE:EXR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held Extra Space Storage Inc. (NYSE:EXR) at the end of the first quarter which was 36 in the previous quarter. While we acknowledge the potential of Extra Space Storage Inc. (NYSE:EXR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Extra Space Storage Inc. (NYSE:EXR) and shared the list of best REIT stocks to buy according to billionaires. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Analysts Offer Insights on Financial Companies: Robinhood (HOOD) and Coinbase Global (COIN)
Analysts Offer Insights on Financial Companies: Robinhood (HOOD) and Coinbase Global (COIN)

Business Insider

timea day ago

  • Business Insider

Analysts Offer Insights on Financial Companies: Robinhood (HOOD) and Coinbase Global (COIN)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Robinhood (HOOD – Research Report) and Coinbase Global (COIN – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Robinhood (HOOD) In a report issued on August 1, Craig Siegenthaler from Bank of America Securities maintained a Buy rating on Robinhood, with a price target of $119.00. The company's shares closed last Friday at $99.90. According to Siegenthaler is a top 100 analyst with an average return of 18.8% and a 64.0% success rate. Siegenthaler covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Apollo Global Management, and Victory Capital Holdings. Robinhood has an analyst consensus of Moderate Buy, with a price target consensus of $108.06, which is a 10.5% upside from current levels. In a report issued on July 17, TR | OpenAI – 4o also upgraded the stock to Buy with a $118.00 price target. Coinbase Global (COIN) Coinbase Global received a Sell rating and a $248.00 price target from Compass Point analyst Ed Engel today. The company's shares closed last Friday at $314.69. Engel has an average return of 0.8% when recommending Coinbase Global. According to Engel is ranked #8697 out of 9897 analysts. Currently, the analyst consensus on Coinbase Global is a Moderate Buy with an average price target of $387.97, implying a 15.8% upside from current levels. In a report issued on August 1, H.C. Wainwright also reiterated a Sell rating on the stock with a $300.00 price target.

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)
Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)

Business Insider

time3 days ago

  • Business Insider

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bausch + Lomb Corporation (BLCO – Research Report), Resmed (RMD – Research Report) and Envista Holdings (NVST – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch + Lomb Corporation (BLCO) J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Bausch + Lomb Corporation on July 30 and set a price target of $13.00. The company's shares closed last Friday at $13.50, close to its 52-week low of $13.16. According to Marcus is a 4-star analyst with an average return of 8.8% and a 52.8% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Merit Medical Systems. Bausch + Lomb Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $14.69, implying an 8.2% upside from current levels. In a report issued on July 30, Needham also maintained a Hold rating on the stock. Resmed (RMD) J.P. Morgan analyst David Low maintained a Buy rating on Resmed yesterday and set a price target of $310.00. The company's shares closed last Friday at $279.20. According to Low is a 4-star analyst with an average return of 7.6% and a 57.0% success rate. Low covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Cochlear, and CSL. Resmed has an analyst consensus of Strong Buy, with a price target consensus of $295.40, implying a 4.8% upside from current levels. In a report released yesterday, KeyBanc also maintained a Buy rating on the stock with a $298.00 price target. Envista Holdings (NVST) J.P. Morgan analyst Rachel Vatnsdal maintained a Hold rating on Envista Holdings yesterday and set a price target of $20.00. The company's shares closed last Friday at $20.83. According to Vatnsdal is a 1-star analyst with an average return of -1.2% and a 39.3% success rate. Vatnsdal covers the Healthcare sector, focusing on stocks such as Caris Life Sciences, Inc., Twist Bioscience, and Myriad Genetics. Envista Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $22.17, which is a 9.6% upside from current levels. In a report issued on July 29, UBS also maintained a Hold rating on the stock with a $22.00 price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store